Please login to the form below

Not currently logged in


This page shows the latest Neutec news and features for those working in and with pharma, biotech and healthcare.

Takeda grows in Turkey with Neutec subsidiary acquisition

Takeda grows in Turkey with Neutec subsidiary acquisition

Takeda grows in Turkey with Neutec subsidiary acquisition. Will acquire Toplam Kalite for up to 300m Turkish lira. ... Japan's Takeda has reached a deal to buy a subsidiary of Turkish pharma company Neutec, giving it a firmer foothold in Turkey's $8.4bn

Latest news

  • Novartis delivers confident outlook despite Chiron costs

    In June, Novartis offered to buy UK firm, NeuTec Pharma for?

  • Keeping afloat

    The higher losses were driven by additional manufacturing and approval costs for Mycograb, one of two drugs NeuTec is developing. ... NeuTec also has Aurograb, a drug being developed to attack the hospital superbug MRSA.

  • High hopes

    The FDA, however, rejected the claims. NeuTec losses widen. Among smaller stocks biopharmaceutical company, NeuTec Pharma, reported increased first-half losses. ... NeuTec is also pinning its hopes on Aurograb, for the treatment of the hospital super bug

  • Stormy seas ahead

    NeuTec Pharma soars on bid talks. NeuTec Pharma, the AIM-listed biotech company, saw its share price rise astronomically by 422p to £10.80p after announcing it is in bid talks. ... Hopeful punters reckon a bid war could develop, pushing NeuTec's share

  • Rocky Road

    and Neutec Pharma going to Novartis for £305m a fortnight ago.

More from news
Approximately 1 fully matching, plus 6 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Four Health Media

Four Health Media creates world class integrated media solutions with global reach, deep insight, innovative methods and a highly personal...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....